Cells MDPI Revenue and Competitors

Basel, Switzerland

Location

N/A

Total Funding

Publishing

Industry

Estimated Revenue & Valuation

  • Cells MDPI's estimated annual revenue is currently $1.5M per year.(i)
  • Cells MDPI's estimated revenue per employee is $145,800

Employee Data

  • Cells MDPI has 10 Employees.(i)
  • Cells MDPI grew their employee count by -17% last year.

Cells MDPI's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Scientific Officer - Physical SciencesReveal Email/Phone
3
Head Information TechnologyReveal Email/Phone
4
Head English Editing DepartmentReveal Email/Phone
5
Head Social Media & Digital MarketingReveal Email/Phone
6
AI Technical LeaderReveal Email/Phone
7
Marketing ManagerReveal Email/Phone
8
Creative Services ManagerReveal Email/Phone
9
Office ManagerReveal Email/Phone
10
Compensation Benefits ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.9M4615%N/AN/A
#2
$1.5M10-17%N/AN/A
#3
$1.5M100%N/AN/A
#4
$2.3M1633%N/AN/A
#5
$3.4M2011%N/AN/A
#6
$1.5M100%N/AN/A
#7
$20.7M85-11%N/AN/A
#8
$4.9M297%N/AN/A
#9
$1.1M913%N/AN/A
Add Company

What Is Cells MDPI?

Cells (ISSN 2073-4409; CODEN: CELLC6) is an international peer-reviewed open access journal of cell biology, molecular biology, and biophysics. Cells is published monthly online by MDPI. Cells covers every topic related to cell biology and physiology, molecular biology, and biophysics. Thus, our major focus is on experimental cytology rather than on clinical and epidemiological studies. More info at https://www.mdpi.com/journal/cells/about

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.5M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cells MDPI News

2022-04-20 - Medigene : publication details augmentation of PRAME-specific TCR-4 by PD1-41BB switch receptor

The Cancers publication is titled "T-Cells Expressing a Highly Potent ... been published online: https://www.mdpi.com/2072-6694/14/8/1998.

2022-04-20 - Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI's specialized ... the Omicron SARS-CoV-2 variant gains access to the human cells by using the...

2022-03-30 - Nanofiber-Hydrogel Treatment for Spinal Cord Injury

Novel research on nervous tissue repair has emerged from the MDPI journal, Cells, through the use of mesenchymal stromal cells and a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M10-9%N/A
#2
$1.5M100%N/A
#3
$0.9M1011%N/A
#4
$1.5M100%N/A
#5
$0.7M12N/AN/A